🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

John J. Doski

ORCID: 0000-0003-4417-0696

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “A Phase 2 Trial of RANKL Antibody, Denosumab, in Two Cohorts of Patients with Recurrent/Refractory Osteosarcoma, a Report from the Children’s Oncology Group”.

A Phase 2 Trial of RANKL Antibody, Denosumab, in Two Cohorts of Patients with Recurrent/Refractory Osteosarcoma, a Report from the Children’s Oncology Group

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-24-2885

N/A

0.104DataRank · unranked

1 citations

Alexander J. Chou, Allen Buxton, Joel M. Reid, Michael S. Isakoff, Lisa M. Kopp +12 more

A Phase III, Randomized, Controlled Trial Comparing Open Versus Thoracoscopic Management of Pulmonary Metastases in Patients with Osteosarcoma

Annals of Surgical Oncology(2022)10.1245/s10434-022-12488-y

N/A

0DataRank · unranked

5 citations

Areeba Saif, Amber Leila Sarvestani, Jonathan M. Hernandez, Timothy B. Lautz, John J. Doski +1 more

AOST2031: An in-progress COG phase 3 randomized controlled trial comparing open vs thoracoscopic management of pulmonary metastases in patients with osteosarcoma.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps11579

N/A

0DataRank · unranked

2 citations

John J. Doski

Incorporation of patient-reported outcomes in pediatric cancer clinical trials: design, implementation, and dissemination

JNCI Journal of the National Cancer Institute(2025)10.1093/jnci/djaf083

N/A

0DataRank · unranked

4 citations

Kathleen Montgomery, Adam DuVall, Michael Roth, Mark Krailo, Michelle M. Nuño +13 more